Effect of 12 Weeks of Treatment with PF-06650833 on Rheumatoid Arthritis

A 12 Week Randomized, Double-Blind, Double Dummy, Parallel Group, Active and Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety Profile of PF-06650833 in Subjects With Active Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
PF-06650833
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7921005
Open Plain Language Summary Result:Click here